Dexcom G7 sensors
Ended Awarded
- Contract number
- SPE2DB25FW3LE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,708
Award facts
- Contract value 100% obligated
- $20,707.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,707.77 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors under a firm fixed-price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. This delivery order represents a non-competitive child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, headquartered in Pennsylvania, serves as a critical pharmaceutical and medical device distributor for the Department of Defense and federal healthcare systems. The company's extensive portfolio under its DLA prime IDC encompasses brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies supporting military healthcare programs globally. This Dexcom G7 sensors delivery order falls within the company's broader role supplying continuous glucose monitoring and diabetes management products to support Defense Health Agency beneficiaries and other government healthcare customers. All of AmerisourceBergen's reviewed contract awards with DLA have been competitively awarded non-set-aside contracts with firm fixed pricing, demonstrating the company's established capability to meet federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FW3LE?
SPE2DB25FW3LE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FW3LE worth?
The government has obligated $20,708 on SPE2DB25FW3LE.
Is contract SPE2DB25FW3LE an order under another contract?
Yes. SPE2DB25FW3LE is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB25FW3LE competed?
The extent of competition for SPE2DB25FW3LE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award